DRG 800: SPLENECTOMY WITH COMPLICATION OR COMORBIDITY (CC) - MARKET SIZE, PREVALENCE, INCIDENCE, QUALITY OUTCOMES, TOP HOSPITALS & PHYSICIANS
Want to know more about Dexur's Capabilities? Get In Touch
Jan 2013 to Dec 2017 | Jan 2017 to Dec 2017
CHARGE CAPTURE ANALYSIS FOR DRG 800: SPLENECTOMY WITH COMPLICATION OR COMORBIDITY (CC) GROUP BASED ON MEDICARE | |
DEMOGRAPHIC DETAILS OF DRG 800: SPLENECTOMY WITH COMPLICATION OR COMORBIDITY (CC) | |
| Race |
Total Hospitalization Volume - Jan 2013 to Dec 2017 |
% of DRG Volume |
|---|
| White |
1,877 |
88.16 |
| Black |
150 |
7.05 |
| Hispanic |
33 |
1.55 |
|
|
|
|
|
|
|
|
|
|
|
|
| Age Group ( Years ) |
Total Hospitalization Volume - Jan 2013 to Dec 2017 |
% of DRG Volume |
|---|
| 65 to 69 |
518 |
24.33 |
| Less than 65 |
507 |
23.81 |
| 70 to 74 |
439 |
20.62 |
|
|
|
|
|
|
|
|
|
TOP ICD DIAGNOSIS CODES FOR DRG 800: SPLENECTOMY WITH COMPLICATION OR COMORBIDITY (CC) | |
TOP ICD PROCEDURE CODES FOR DRG 800: SPLENECTOMY WITH COMPLICATION OR COMORBIDITY (CC) | |
TOP HOSPITALS ASSOCIATED WITH DRG 800: SPLENECTOMY WITH COMPLICATION OR COMORBIDITY (CC) | |
TOP ATTENDING PHYSICIAN ASSOCIATED WITH DRG 800: SPLENECTOMY WITH COMPLICATION OR COMORBIDITY (CC) | |
| Physician Name |
Address |
City |
State |
Zip Code |
Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 |
% of DRG Volume |
| DR. DAVID M NAGORNEY |
200 1ST ST SW |
ROCHESTER |
MN |
55905 |
11 |
0.52 |
TOP OPERATING PHYSICIAN ASSOCIATED WITH DRG 800: SPLENECTOMY WITH COMPLICATION OR COMORBIDITY (CC) | |
| Physician Name |
Address |
City |
State |
Zip Code |
Total Physician & DRG Hospitalization Volume - Jan 2013 to Dec 2017 |
% of DRG Volume |
| DR. DAVID M NAGORNEY |
200 1ST ST SW |
ROCHESTER |
MN |
55905 |
11 |
0.52 |
DRG 800: SPLENECTOMY WITH COMPLICATION OR COMORBIDITY (CC) SUMMARY TABLE | |
| Category |
Sub Category |
DRG Group |
ICD Codes |
ICD Description |
National Projected Hospitalizations (Present on Admission - All) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - All) Jan 2013 to Dec 2017 |
National Projected Hospitalizations(Present on Admission - Yes) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - Yes) Jan 2013 to Dec 2017 |
National Projected Hospitalizations (Present on Admission - Not Y) Jan 2016 to Dec 2016 |
Medicare Hospitalizations (Present on Admission - Not Y) Jan 2013 to Dec 2017 |
Total Discharges After Exclusion |
Avg. LOS |
GMLOS |
All Cause Readmission Rate (%) |
Unplanned Readmission Rate (%) |
Total Medicare Payments |
Payment per Day |
Payment per Discharge |
Total Medicare Charges |
Avg. Charges |
Mortality Rate (%) |
SNF Discharge Rate (%) |
Home Discharge Rate (%) |
| General Surgery |
Splenectomy |
Splenectomy |
4019 |
Unspecified essential hypertension |
NA |
607 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| General Surgery |
Splenectomy |
Splenectomy |
I10 |
Essential (primary) hypertension |
624 |
437 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| General Surgery |
Splenectomy |
Splenectomy |
28731 |
Immune thrombocytopenic purpura |
NA |
378 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| General Surgery |
Splenectomy |
Splenectomy |
7892 |
Splenomegaly |
NA |
372 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| General Surgery |
Splenectomy |
Splenectomy |
2724 |
Other and unspecified hyperlipidemia |
NA |
362 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| General Surgery |
Splenectomy |
Splenectomy |
53081 |
Esophageal reflux |
NA |
304 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| General Surgery |
Splenectomy |
Splenectomy |
R161 |
Splenomegaly, not elsewhere classified |
412 |
283 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| General Surgery |
Splenectomy |
Splenectomy |
2851 |
Acute posthemorrhagic anemia |
NA |
273 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| General Surgery |
Splenectomy |
Splenectomy |
25000 |
Diabetes mellitus without mention of complication, type II or unspecified type, not stated as uncontrolled |
NA |
273 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| General Surgery |
Splenectomy |
Splenectomy |
V1582 |
Personal history of tobacco use |
NA |
261 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|